At CES, the global content, entertainment and story platform leaned into its AI and tech offerings to reassure investors.

Busy day at Google today: the company rolled out version 2.0 of its Gemini AI assistant (previously announced in December) ...

This was the stock's fourth consecutive day of gains.

Human brains today contain 50% more plastic than in 2016, a new study found. Brain of people diagnosed with dementia had the ...

The White House faces a decision on how to move forward with director of national intelligence nominee Tulsi Gabbard — wait ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach and ...

Piper Sandler made a slight adjustment to the price target of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), bringing it down to $533 from the previous target of $535, while maintaining an ...

Photo and Information Center Welcomes You! The Photo and Information Center (PIC) is open Monday-Friday, 8:00-5:00. These days, image is everything. At the PIC, we have what you need to take your ...